Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | FABP7 | O15540 | 1/20 | 0.35 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4732903 | 0.86 | CA1 (0.42) | SIGMAR1RAB9AFABP7FABP5ALDH1A1 | |
| SCHEMBL7690874 | 0.82 | RAB9A (0.38) | SIGMAR1RAB9AALDH1A1EDNRAKMT2A | |
| SCHEMBL7063571 | 0.82 | SIGMAR1 (0.40) | SIGMAR1PPARGALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL14967701 | 0.72 | SIGMAR1 (0.42) | SIGMAR1FFAR1ALDH1A1EDNRASMN1; SMN2 | |
| SCHEMBL16109499 | 0.70 | SIGMAR1 (0.41) | SIGMAR1PPARGRAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL14967013 | 0.70 | MIF (0.41) | SIGMAR1ALDH1A1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL16109557 | 0.70 | PPARG (0.42) | SIGMAR1PPARGALDH1A1LMNAHSD17B10 | |
| SCHEMBL16746581 | 0.69 | TSHR (0.44) | PPARGFABP7FABP5ALDH1A1EDNRA | |
| SCHEMBL16109798 | 0.69 | L3MBTL1 (0.40) | SIGMAR1PPARGRAB9AALDH1A1LMNA | |
| SCHEMBL14967096 | 0.69 | MIF (0.39) | SIGMAR1ALDH1A1LMNAHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2768820-A2 | A PROCESS FOR MAKING AN INTERMEDIATE OF CABAZITAXEL | Scinopharm Taiwan Ltd. (TW) | 2014-08-27 | — | — | EP | disclosed |
| WO-2013054204-A2 | A PROCESS FOR MAKING AN INTERMEDIATE OF CABAZITAXEL | SCINOPHARM TAIWAN LTD. (TW) | 2013-04-18 | — | — | WO | disclosed |
| EP-2108014-A1 | METHOD OF PREPARING DOCETAXEL AND INTERMEDIATES USED THEREIN | Hanmi Pharm. Co., Ltd. (KR) | 2009-10-14 | — | — | EP | disclosed |
| WO-2008072849-A1 | METHOD OF PREPARING DOCETAXEL AND INTERMEDIATES USED THEREIN | HANMI PHARM. CO., LTD. (KR) | 2008-06-19 | — | — | WO | disclosed |
| EP-0876361-A1 | 4,10$g(b)-DIACETOXY-2$g(a)-BENZOYLOXY-5$g(b),20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA G]TAX-11-ENE-13$g(a)-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | Aventis Pharma S.A. (FR) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997021695-A1 | 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME | RHONE-POULENC RORER S.A. (FR) | 1997-06-19 | — | — | WO | disclosed |